Cardinal Health (NYSE:CAH – Get Free Report) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday, Wall Street Zen reports.
A number of other equities analysts have also recently issued reports on CAH. Leerink Partners set a $292.00 target price on Cardinal Health in a report on Tuesday, August 11th. Morgan Stanley boosted their target price on Cardinal Health from $265.00 to $286.00 and gave the stock an “overweight” rating in a research report on Friday, October 30th. TD Cowen increased their price target on Cardinal Health from $280.00 to $304.00 and gave the company a “buy” rating in a research report on Monday, November 9th. Mizuho set a $290.00 price objective on Cardinal Health in a report on Thursday, November 5th. Finally, Royal Bank Of Canada upped their price objective on shares of Cardinal Health from $276.00 to $295.00 and gave the company an “outperform” rating in a research note on Friday, November 6th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $290.13.
Get Our Latest Analysis on Cardinal Health
Cardinal Health Stock Performance
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.94 by $0.32. The firm had revenue of $67.51 billion for the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.55 earnings per share. On average, sell-side analysts expect that Cardinal Health will post 12.96 EPS for the current fiscal year.
Hedge Funds Weigh In On Cardinal Health
Institutional investors and hedge funds have recently modified their holdings of the stock. Pinnacle Associates Ltd. boosted its position in Cardinal Health by 2.9% during the third quarter. Pinnacle Associates Ltd. now owns 1,404 shares of the company’s stock valued at $312,000 after purchasing an additional 39 shares during the last quarter. Composition Wealth LLC increased its position in Cardinal Health by 1.7% in the 3rd quarter. Composition Wealth LLC now owns 2,383 shares of the company’s stock worth $530,000 after purchasing an additional 39 shares during the last quarter. Parallel Advisors LLC increased its position in Cardinal Health by 1.4% in the 3rd quarter. Parallel Advisors LLC now owns 3,004 shares of the company’s stock worth $668,000 after purchasing an additional 41 shares during the last quarter. LWM Advisors Inc. raised its stake in shares of Cardinal Health by 4.4% during the 2nd quarter. LWM Advisors Inc. now owns 1,028 shares of the company’s stock worth $244,000 after purchasing an additional 43 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its stake in shares of Cardinal Health by 2.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,793 shares of the company’s stock worth $426,000 after purchasing an additional 43 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Cardinal Health Company Profile
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Featured Articles
- Five stocks we like better than Cardinal Health
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
